Status:
COMPLETED
Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder.
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Overactive Bladder
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Overactive bladder induce urgency, urge incontinence, nocturia and pollakiuria. This condition is often resistant to anticholinergic drugs used as a first line treatment for this purpose. Moreover mus...
Detailed Description
This study is designed to evaluate the efficacy and safety of botulinum toxin A injected into the detrusor muscle to control symptoms and improve quality of life for patients resistant or intolerant t...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Overactive bladder with more than 3 episodes of urgency of urge incontinence per day
Exclusion
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00231491
Start Date
November 1 2005
End Date
April 1 2010
Last Update
February 17 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
RAYMOND POINCARE Hospital
Garches, France, 92380